Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic victims and fund addiction treatment programs. The Stamford, Connecticut ...

Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion in cash to creditors, subject to certain reserves, to compensate victims and abate the opioid crisis.

STAMFORD, Conn., March 19, 2025--Purdue Pharma L.P. ("Purdue") today filed a Chapter 11 Plan of Reorganization (the "Plan") and related disclosure statement with the United States Bankruptcy Court ...

Purdue Pharma on Wednesday filed a new bankruptcy reorganization plan to resolve mass lawsuits alleging that the OxyContin maker and its Sackler family owners contributed to the opioid crisis.

Purdue Pharma files new bankruptcy plan to settle opioid lawsuits. Sackler family to pay $1.5 billion on settlement date, with $6.5 billion over 15 years.

Reuters. FILE PHOTO: Bottles of prescription painkiller OxyContin pills, made by Purdue Pharma LP sit on a counter at a local pharmacy in Provo, Utah, U.S., April 25, 2017.

NEW YORK (Reuters) -Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after a setback ...

— Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin ...

Purdue Pharma files new bankruptcy plan to settle opioid lawsuits. Sackler family to pay $1.5 billion on settlement date, with $6.5 billion over 15 years.